A new study suggests that a novel anti-clotting drug may reduce the risk of a second stroke without increasing bleeding, ...
OCEANIC-STROKE randomized 12,327 patients within 72 hours of noncardioembolic stroke or high-risk TIA to asundexian 50 mg daily versus placebo atop single or dual antiplatelet therapy. A 26% relative ...
Initiating the oral anticoagulant apixaban in patients undergoing kidney dialysis who also had newly diagnosed atrial fibrillation (AF) was associated with fewer strokes and deaths but higher rates of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results